Nivagen Raises Cash To Fuel Growth

More Financing In The Works, CEO Says

California-based Nivagen is continuing to raise money to push through a number of generic launches in the US this year, the company’s founder and chief Jay Shukla told Generics Bulletin.

US_Dollars
Another round of financing by Nivagen will help push generics through this year. • Source: Shutterstock

North American generics specialist Nivagen Pharmaceuticals has secured an $8m credit facility with help from commercial finance advisors Business Capital, providing some of the firepower to launch almost 10 new generics this year.

The debt, which is secured on assets, will hand the firm “the necessary working capital to facilitate its growth as...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business